Literature DB >> 9555008

The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats.

Y Nakagawa1, T Ishima, T Takashima.   

Abstract

Involvement of 5-hydroxytryptamine (5-HT)3 receptors in action of antidepressants was examined in the forced swim test in rats. Rats were forced to swim in a cylinder for 15 min on day 1 and for 5 min on day 2. Imipramine, desipramine and mianserin, administered after the 15-min swim session on day 1 and before the 5-min swim test on day 2, dose-dependently decreased the duration of immobility in the swim test on day 2. 1-(m-Chlorophenyl)-biguanide (mCPBG) attenuated the decreased duration of immobility induced by imipramine, desipramine and mianserin, although mCPBG did not affect the duration of immobility when it was given alone. ICS205-930 dose-dependently decreased the duration of immobility in the swim test on day 2, and the effect of ICS205-930 was attenuated by mCPBG. These results suggest that the suppression of 5-HT3 receptor activity may contribute to the action of antidepressants. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555008     DOI: 10.1016/s0006-8993(97)01459-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  Modulation of ligand-gated ion channels by antidepressants and antipsychotics.

Authors:  Gerhard Rammes; Rainer Rupprecht
Journal:  Mol Neurobiol       Date:  2007-04       Impact factor: 5.590

2.  Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.

Authors:  S Body; K Asgari; J F Rickard; Z Zhang; K C F Fone; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

Review 3.  The role of serotonin receptor subtypes in treating depression: a review of animal studies.

Authors:  Gregory V Carr; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-11-24       Impact factor: 4.530

4.  Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Caterina Scuderi; Baoman Li
Journal:  Adv Neurobiol       Date:  2021

Review 5.  Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease.

Authors:  Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2008-03-26       Impact factor: 8.989

6.  Patch Clamp Study of Serotonin-Gated Currents via 5-HT Type 3 Receptors by Using a Novel Approach SHAM for Receptor Channel Scanning.

Authors:  Fatima-Shad Kaneez; M. White
Journal:  J Biomed Biotechnol       Date:  2004

7.  Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT(3) receptor antagonist: an investigation in behaviour-based rodent models of depression.

Authors:  Radhakrishnan Mahesh; Baldev Kumar; Ankur Jindal; Shvetank Bhatt; Thangaraj Devadoss; Dilip Kumar Pandey
Journal:  Indian J Pharmacol       Date:  2012 Sep-Oct       Impact factor: 1.200

8.  Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models.

Authors:  R Rajkumar; R Mahesh
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

9.  Genetic variations in the serotonergic system contribute to amygdala volume in humans.

Authors:  Jin Li; Chunhui Chen; Karen Wu; Mingxia Zhang; Bi Zhu; Chuansheng Chen; Robert K Moyzis; Qi Dong
Journal:  Front Neuroanat       Date:  2015-10-09       Impact factor: 3.856

10.  Antidepressant-like effect of a novel 5-HT3 receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests.

Authors:  Yeshwant Kurhe; Radhakrishnan Mahesh; Thangaraj Devadoss; Deepali Gupta
Journal:  J Pharmacol Pharmacother       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.